Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases.

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

By Sneha S K April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse ...

Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain ...

As clinicians celebrated results of the PALOMA-2 study at ASCO Annual Meeting in 2016, Gabe S. Sonke, MD, PhD, had a question ...

The Alliance for Clinical Trials in Oncology is now enrolling patients into a clinical trial aimed at helping women recover ...

A new study led by researchers at the Institute of Materials Science of Barcelona (ICMAB-CSIC) reveals why a particular boron ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that ...

Regeneron Pharmaceuticals plans to expand its pipeline into radiopharmaceutical therapies through an up to $4.3 billion collaboration with Telix Pharmaceuticals to co-develop and co-commercialize ...

Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...

Patients with elevated anti-HLA antibodies experienced significantly prolonged time to transplant — a median of 120 days ...